Correlation Between Cannabics Pharmaceuticals and Entia Biosciences

Can any of the company-specific risk be diversified away by investing in both Cannabics Pharmaceuticals and Entia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabics Pharmaceuticals and Entia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannabics Pharmaceuticals and Entia Biosciences, you can compare the effects of market volatilities on Cannabics Pharmaceuticals and Entia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabics Pharmaceuticals with a short position of Entia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabics Pharmaceuticals and Entia Biosciences.

Diversification Opportunities for Cannabics Pharmaceuticals and Entia Biosciences

0.0

Correlation Coefficient

Cannabics Pharmaceuticals  Entia Biosciences

Pay attention - limited upside

The 3 months correlation between Cannabics and Entia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannabics Pharmaceuticals and Entia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entia Biosciences and Cannabics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabics Pharmaceuticals are associated (or correlated) with Entia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entia Biosciences has no effect on the direction of Cannabics Pharmaceuticals i.e., Cannabics Pharmaceuticals and Entia Biosciences go up and down completely randomly.

Pair Corralation between Cannabics Pharmaceuticals and Entia Biosciences

If you would invest  1.00  in Cannabics Pharmaceuticals on October 11, 2024 and sell it today you would earn a total of  0.00  from holding Cannabics Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Cannabics Pharmaceuticals  vs.  Entia Biosciences

Cannabics Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Entia Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Entia Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Entia Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Cannabics Pharmaceuticals and Entia Biosciences

The main advantage of trading using opposite Cannabics Pharmaceuticals and Entia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabics Pharmaceuticals position performs unexpectedly, Entia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will offset losses from the drop in Entia Biosciences' long position.

The idea behind Cannabics Pharmaceuticals and Entia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.